New eBook: The role of real-world evidence in FDA approvals. Download now.

Real-world evidence and COVID-19: Empower rapid, reliable, data science-driven decisions

Liz DeMatteis
Chief Marketing Officer, Aetion

Abby Stockwell
Senior Marketing Director, HealthVerity

Image for Real-world evidence and COVID-19: Empower rapid, reliable, data science-driven decisions
Image for Real-world evidence and COVID-19: Empower rapid, reliable, data science-driven decisions

The COVID-19 pandemic has triggered intense and widespread action among the biopharma industry and its regulators. As organizations move to accelerate interventions to treat and prevent COVID-19, understanding the impact on patient populations and subpopulations is critical.

This need comes as the clinical trial infrastructure is disrupted—nearly two-thirds of 170 clinical trial sites surveyed in the U.S. believe patients will be less likely to enroll in new clinical research trials due to COVID-19—and biopharma may need to turn to non-traditional trials to help answer questions on the safety and effectiveness of treatments.

With so much at stake, we must act quickly to assess and advance treatments for COVID-19, yet no less rigorously in upholding evidence standards. Manufacturers and regulators need reliable, replicable, and transparent evidence now more than ever.

That is why HealthVerity and Aetion have launched Real-Time Insights and Evidence, the first and only real-world evidence system that combines COVID-ready analytics with near real-time data, to assess treatment approaches for COVID-19. 

Real-world evidence can and must play an important role in addressing these high-stakes questions in the current climate. We’ve amassed data that cut across care settings and that are simultaneously current and complete, along with regulatory-grade analytic capabilities to help manufacturers and regulators quickly reach valid answers. 

HealthVerity and Aetion created this offering to meet this challenge: to support in-the-moment and adaptive response as data accrue, to enable decision-ready evidence, and to ensure transparency around its generation—to determine which treatments work best, for whom, and when.

COVID-19 is an unprecedented shock to the health care system. Joined together and with our biopharma partners, we’re ready for the hard work ahead. 

The Evidence Digest

Subscribe to our newsletter for insights and updates on research and applications for real-world evidence in life sciences and value-based health care.

eBook

The role of real-world evidence in FDA approvals

View now
arrowcalendarchevronclosecollapsecountdownfacebookflickrinstagramlinelinkedinlocationpinsearchsocialtwitteryoutube